Profile data is unavailable for this security.
About the company
Cowealth Medical China Co Ltd is a China-based company mainly engaged in the wholesale of medical equipment products. The Company's businesses include in-vitro diagnostic product intensive business and medical product distribution business. The in-vitro diagnostic product intensive business is engaged in the wholesale business of in vitro diagnostic products, mainly including immunodiagnosis, biochemical diagnosis, clinical testing, real-time testing, molecular diagnosis, pathology, microbiological testing, blood source safety monitoring and others. The medical product distribution business mainly includes the wholesale sales of equipment in the field of swelling, immunodiagnosis and biochemical diagnosis. The Company mainly operates its business in the domestic market.
- Revenue in CNY (TTM)777.03m
- Net income in CNY-11.37m
- Incorporated2000
- Employees203.00
- LocationCowealth Medical China Co Ltd1F, Guangqi Building, 456 Hongcao RoadSHANGHAI 200233ChinaCHN
- Phone+86 2 160378999
- Fax+86 2 160378951
- Websitehttps://ch.cowealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Bioperfectus Technologies Co Ltd | 339.03m | -25.96m | 5.66bn | 592.00 | -- | 1.91 | -- | 16.70 | -0.3096 | -0.3096 | 4.04 | 35.38 | 0.0903 | 1.85 | 6.13 | 572,683.70 | -0.6919 | 20.36 | -0.796 | 24.55 | 58.22 | 62.71 | -7.66 | 31.89 | 3.22 | -- | 0.1329 | 28.76 | -13.29 | 3.90 | 99.46 | -- | -9.88 | -- |
| Qingdao NovelBeam Technology Co Ltd | 571.80m | 174.33m | 5.68bn | 841.00 | 32.62 | 4.31 | -- | 9.93 | 1.45 | 1.45 | 4.76 | 10.99 | 0.3817 | 0.9932 | 5.67 | 679,901.10 | 11.39 | 12.70 | 12.61 | 14.11 | 64.34 | 63.15 | 29.84 | 33.96 | 3.43 | 51.04 | 0.1058 | 40.95 | -5.90 | 11.86 | -7.11 | 13.48 | 13.44 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 671.62m | -72.38m | 5.69bn | 1.22k | -- | 4.57 | -- | 8.48 | -0.5475 | -0.5475 | 5.10 | 9.25 | 0.3834 | 1.02 | 2.29 | 552,775.60 | -4.14 | 3.01 | -5.15 | 3.34 | 61.79 | 68.86 | -10.80 | 7.52 | 1.57 | -- | 0.2086 | 43.30 | 10.54 | 20.28 | -63.68 | -16.86 | 23.29 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.05bn | 251.02m | 5.85bn | 1.67k | 23.11 | 2.78 | -- | 5.55 | 0.5907 | 0.5907 | 2.47 | 4.90 | 0.3855 | 2.51 | 5.74 | 631,202.60 | 8.98 | 14.03 | 12.10 | 17.34 | 61.03 | 62.46 | 23.30 | 27.25 | 3.00 | -- | 0.1406 | 39.01 | 0.2024 | 22.12 | 5.12 | 27.99 | -1.63 | 18.64 |
| Hangzhou Biotest Biotech Co Ltd | 478.69m | 102.57m | 6.01bn | 603.00 | 57.81 | 2.57 | -- | 12.56 | 0.6964 | 0.6964 | 3.06 | 15.66 | 0.1913 | 3.20 | 5.70 | 793,854.10 | 4.02 | 23.63 | 4.25 | 26.20 | 50.57 | 56.59 | 21.00 | 41.47 | 13.08 | -- | 0.00008 | 34.42 | 26.53 | 21.78 | 59.01 | 43.12 | 44.08 | -- |
| Cowealth Medical China Co Ltd | 777.03m | -11.37m | 6.57bn | 203.00 | -- | 5.94 | -- | 8.45 | -0.0285 | -0.0285 | 1.97 | 2.78 | 0.5206 | 3.32 | 1.00 | 3,827,724.00 | -0.7168 | 4.75 | -0.9393 | 6.35 | 16.38 | 20.19 | -1.38 | 5.56 | 2.65 | -- | 0.0229 | 33.36 | -14.05 | -2.15 | -41.58 | -16.31 | 2.73 | -- |
| Shanghai Sanyou Medical Co Ltd | 512.33m | 64.88m | 7.42bn | 514.00 | 98.86 | 3.58 | -- | 14.48 | 0.2251 | 0.2251 | 1.58 | 6.22 | 0.2213 | 0.5263 | 6.23 | 996,747.10 | 2.51 | 6.73 | 2.86 | 7.78 | 73.35 | 83.31 | 11.33 | 25.25 | 3.81 | -- | 0.0204 | 18.72 | -1.48 | 5.06 | -88.00 | -34.86 | -14.02 | -- |
| Beijing Chunlizhengda Mdicl Instr Co Ltd | 1.05bn | 255.37m | 7.60bn | 1.24k | 33.10 | 2.86 | -- | 7.21 | 0.6729 | 0.6729 | 2.78 | 7.78 | 0.2995 | 0.6437 | 3.48 | 851,792.40 | 7.26 | 9.44 | 8.55 | 11.52 | 64.99 | 72.15 | 24.23 | 25.01 | 5.09 | -- | 0.00007 | 24.89 | -33.32 | -1.18 | -55.01 | -11.99 | -17.97 | -- |
Data as of Feb 13 2026. Currency figures normalised to Cowealth Medical China Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.70%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Gfund Management Co., Ltd.as of 30 Jun 2025 | 519.70k | 0.29% |
| CCB Principal Asset Management Co., Ltd.as of 30 Jun 2025 | 470.80k | 0.26% |
| Hongde Fund Management Co., Ltd.as of 30 Jun 2025 | 55.70k | 0.03% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2025 | 52.70k | 0.03% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 47.30k | 0.03% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 40.20k | 0.02% |
| Truvalue Asset Management Co. Ltd.as of 30 Jun 2025 | 33.00k | 0.02% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 22.20k | 0.01% |
| Springs Fund Management Co. Ltd.as of 30 Jun 2025 | 10.90k | 0.01% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 8.00k | 0.00% |
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
